Disparities and Determinants of Testing for Early Detection of Cervical Cancer among Nepalese Women: Evidence from a Population-Based Survey

Author:

Rahman Md. Shafiur12ORCID,Rahman Md. Mahfuzur3ORCID,Acharya Kiran4ORCID,Haruyama Rei5ORCID,Shah Richa6ORCID,Matsuda Tomohiro7ORCID,Inoue Manami1ORCID,Abe Sarah K.1ORCID

Affiliation:

1. Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan. 1

2. Research Centre for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan. 2

3. Graduate School of Public Health, St. Luke’s International University, Tokyo, Japan. 3

4. New ERA, Rudramati Marga, Kathmandu, Nepal. 4

5. Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan. 5

6. Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France. 6

7. Division of International Health Policy Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan. 7

Abstract

Abstract Background: Cervical cancer presents a considerable challenge in South Asia, notably in Nepal, where screening remains limited. Past research in Nepal lacked national representation and a thorough exploration of factors influencing cervical cancer screening, such as educational and socioeconomic disparities. This study aims to measure these gaps and identify associated factors in testing for early detection of cervical cancer among Nepalese women. Methods: Data from the 2019 Nepal Noncommunicable Disease Risk Factors survey (World Health Organization STEPwise approach to noncommunicable risk factor surveillance), involving 2,332 women aged 30 to 69 years, were used. Respondents were asked if they had undergone cervical cancer testing through visual inspection with acetic acid, Pap smear, or human papillomavirus test ever or in the past 5 years. The slope index of inequality (SII) and relative concentration index were used to measure socioeconomic and education-based disparities in cervical cancer test uptake. Results: Only 7.1% [95% confidence interval (CI): 5.1–9.9] Nepalese women had ever undergone cervical cancer testing, whereas 5.1% (95% CI: 3.4–7.5) tested within the last 5 years. The ever uptake of cervical cancer testing was 5.1 percentage points higher (SII: 5.1, 95% CI: −0.1 to 10.2) among women from the richest compared with the poorest households. Education-based disparities were particularly pronounced, with a 13.9 percentage point difference between highly educated urban residents and their uneducated counterparts (SII: 13.9, 95% CI: 5.8–21.9). Conclusions: Less than one in ten women in Nepal had a cervical cancer testing, primarily favoring higher educated and wealthier individuals. Impact: Targeted early detection and cervical cancer screening interventions are necessary to address these disparities and improve access and uptake.

Publisher

American Association for Cancer Research (AACR)

Reference65 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative;Singh;Lancet Glob Health,2023

3. Towards elimination of cervical cancer–human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries;Ong;Lancet Reg Health West Pac,2023

4. State of non-communicable diseases in Nepal;Bhandari;BMC Public Health,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3